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Purpose: As the National Health Insurance Service (NHIS) began to cover home oxygen therapy (HOT) services 
from 2006, it is expected that the new services have contributed to overall positive outcome of patients with 
chronic obstructive pulmonary disease (COPD). We examined whether the usage of HOT has helped slow down 
the progression of COPD. Methods: We examined hospital claim data (N=10,798) of COPD inpatients who 
were treated in 2007∼2012. We performed χ2 tests to analyze the differences in the changes to respiratory 
impairment grades. Multiple logistic regression analysis was used to identify factors that are associated with the 
use of HOT. Finally, a generalized linear mixed model was used to examine association between the HOT treatment 
and changes to respiratory impairment grades. Results: A total of 2,490 patients had grade 1 respiratory 
impairment, and patients with grades 2 or 3 totaled 8,308. The OR for use of HOT was lower in grade 3 patients 
than others (OR: 0.33, 95% CI: 0.30∼0.37). The maintenance/mitigation in all grades, those who used HOT 
had a higher OR than non-users (OR: 1.41, 95% CI: 1.23∼1.61). Conclusion: HOT was effective in maintaining 
or mitigating the respiratory impairment in COPD patients.
Key Words: Chronic obstructive pulmonary disease, Oxygen inhalation therapy, Home care services, Respiratory 
mechanics
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) causes 
closure of the airway without lung/heart disease as a particular 
cause. It causes continuous aggravation of lung function, 
which can lead to death (1-3). According to the 2011 World 
Health Organization (WHO), 6,400 million people worldwide 
suffer from COPD, and COPD was ranked fourth among all 
causes of death (4). Thus, COPD has a substantial impact on 
the health of the world's population. According to the 
National Health Insurance Service (NHIS), the number of 
COPD patients who visit medical institutions has increased to 
more than 200,000 in one year during the 21st century (5). 
Patients with COPD show gradual deterioration, and could 
have respiratory impairment or live with poor quality of life 
(6-9). 
Although there is no cure for COPD, some treatments and 
life style changes, such as taking bronchodilators and quitting 
smoking, can help the patients feel better and keep the 
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disease from getting worse (10). In severe cases, however, 
other types of treatment, such as oxygen therapy and surgery, 
may also be required (11). Particularly, those who need 
long-term oxygen therapy may need to get the service at 
home.
Prior studies suggest the following positive effects of using 
home oxygen therapy (HOT): improvement in survival and 
prognosis of patients with respiratory disease, decrease of 
polycythemia, prevention of occurrence of pulmonary hyper-
tension, and enhancement of neuropsychological health (12-21).
While HOT can be expensive, it had not been covered by 
the National Health Insurance (NHI) scheme in Korea, which, 
therefore, caused significant financial barriers for COPD patients 
accessing the service. As policies aimed to expand overall 
health insurance benefits were introduced in Korea in the 
mid-2000s, the NHIS finally started covering HOT service in 
2006. Thus, patients who are determined as Grade 1 or 
Grade 2 of respiratory impairment and patients that meet the 
coverage criteria through arterial blood gas test or examination 
of oxygen saturation have been entitled to use the HOT, by 
paying for 20 percent of the monthly charge. This appears to 
contribute to overall increase in the number of patients with 
respiratory impairment who use HOT service. According to 
the statistics, the percentage of those who use HOT increased 
from 34.1% in 2008 to 53.4% in 2011 (22).
While it is expected that this newly covered service has 
contributed to overall positive outcome of the COPD patients, 
there is limited empirical evidence on whether this really has 
been the case. Therefore, we examined whether the usage of 
HOT services has helped slow down the progression of 
COPD.
MATERIALS AND METHODS
1. Study population
In order to examine the effect of using a HOT service, we 
used hospital claim data on COPD inpatients during 2007∼
2012. Among them, we selected COPD patients with 
respiratory impairment grades 1, 2, and 3, and followed up 
on the changes in their grades. We excluded variables with 
missing values, Medical-Aid beneficiaries, and participants who 
died during the study period, which leaves 10,798 cases in the 
final analysis.
2. Variables
The outcome variables in this study were the changes of 
respiratory impairment grade. Changes of respiratory impairment 
grade were divided into two groups by grade: Grade 1; 1) 
maintenance/deterioration and 2) mitigation, Grade 2/3; 1) 
deterioration and 2) maintenance/mitigation.
The independent variable of main interest in relation to the 
change of respiratory impairment grade was the usage of 
HOT by the patients. Other independent variables considered 
in the analysis as potential confounding variables were the 
grade of respiratory impairment, sex, age, type of medical 
institution, length of stay, experience of care in intensive care 
unit (ICU), experience of ventilator care, and years.
The grades of respiratory impairment were classified according 
to three stages. Judgment of grade was implemented according 
to the following criteria. Grade 1/2/3 was defined as chronic 
function failure in lung or bronchus requiring oxygen therapy, 
even at rest/while moving in home/while walking, as well as 
patients with a pulmonary function lower than 25%/35%/40% 
of normal value or who had partial pressure of arterial blood 
gas less than 55 mmHg/60 mmHg/65 mmHg. By using this 
variable, it could be reflect severity of patients with COPD as 
indirectly (23). Age groups were divided as follows: younger 
than 49 years, 50∼59 years, 60∼69 years, and older than 
70 years. Types of medical institution were defined as 
“General hospital” or “Hospital, Clinic” by patient visits as 
COPD. It could consider structural characteristics of each 
hospital (24). Length of stay was defined as the number of 
hospitalization days per inpatient. These were classified 
according to four groups: “Within 10 days”, “10∼29 days”, 
and “More than 30 days”. Experience of care in ICU or 
ventilator care was used to consider severity of COPD 
patients. Therefore, it could be possible to analyze reflecting 
patient’s mix (25).
3. Statistical analysis
We examined the distribution of each categorical variable 
according to frequency and percentages and performed χ2 
tests to examine the differences in each variable according to 
the changes of respiratory impairment grade and usage of 
oxygen therapy. We used the multiple logistic regression 
analysis to examine the factors that are associated with the 
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use of HOT. In addition, a generalized linear mixed model 
was used to incorporate repeated-measures variables and to 
examine the association between usage of HOT service and 
changes of respiratory impairment grade, while controlling for 
potential confounding variables, including the grade of 
respiratory impairment, sex, age, type of medical institution, 
length of stay, experience of care in ICU, experience of 
ventilator care, and years. All statistical analyses were performed 
using SAS statistical software (Cary, NC) version 9.2. All 
reported p-values are two-sided and considered significant 
when P＜0.05.
RESULTS
The data used in this analysis consisted of 10,798 patients. 
Among them, 4,371 patients who had used HOT and 6,427 
patients who not used HOT. Among users for HOT, male 
was more slow down for progression of COPD (Male: 74.8%, 
Female: 67.9%) than female. Furthermore, number of 
mitigated or maintained patients were lower in older groups 
than youngers (Less than 49: 77.7%, 50∼59: 72.8%, 60∼
69: 67.8%, More than 70: 55.4%), higher for people who 
used the hospital or clinic (Hospital, Clinic: 81.6%, General 
hospital: 71.9%), and higher for patients with longer length 
of stay (Within 10days: 70.6%, 10∼29days: 73.5%, More 
than 30 days: 85.7%). Among non-users for HOT, number of 
maintenance and mitigated patients by sex was contrast with 
results in users (Male: 66.3%, Female: 72.9%). On the other 
hand, we founded similar results in users by age-groups (Less 
than 49: 73.5%, 50∼59: 63.2%, 60∼69: 61.2%, More than 
70: 47.1%), hospitalized in hospital or clinic (Hospital, Clinic: 
79.4%, General hospital: 62.4%), and patients with longer 
length of stay (Within 10days: 62.0%, 10∼29 days: 69.2%, 
More than 30 days: 91.1%). Finally people who experienced 
ICU care were less frequent than non-experienced group 
(“Yes”: 50.0%, “No”: 67.9%) (Table 1). 
Table 2 shows the results of the multiple logistic regression 
analysis on the factors associated with using HOT. The odds 
ratio (OR) for use of HOT was lower in grade 3 than grade 
1 and 2 (OR: 0.33, 95% Confidence Intervals; 95% CI: 0.30∼
0.37). And, female patients had lower odds ratio than male 
patients (OR: 0.86, 95% CI: 0.77∼0.95). By the age-group, 
older groups were more likely to use HOT than younger 
groups. We also found that participants who stayed longer 
than 30 days had a significantly higher odds ratio for 
maintenance/mitigation (OR: 1.25, 95% CI: 1.09∼1.45). 
Also, people who did not receive the ventilator care had lower 
odds ratio than those who did (OR: 0.37, 95% CI: 0.30∼
0.45) (Table 2).
Table 3 shows the results of the analysis using the 
generalized linear mixed model. As expected, for the 
maintenance/mitigation in all grades, those who used HOT 
had a higher odds ratio, compared to those who did not use 
(OR: 1.41, 95% CI: 1.23∼1.61). By age-group, a lower odds 
ratio was observed for older age groups compared with lower 
age groups. The highest odds ratio was observed for 
participants who had a length of stay more than 30 days 
(OR: 2.54, 95% CI: 2.00∼3.22) (Table 3).
DISCUSSION
In our study, we investigated the association of usage of 
HOT with the change of respiratory impairment grade among 
COPD patients after the NHI scheme began to cover the 
service in November 2006.
The results of the study show that use of a HOT service 
was effective in maintaining or mitigating the grade of 
respiratory impairment of COPD patients. Since COPD is a 
chronic disease, its symptoms tend to get worse with time. 
Therefore, preventing the loss of quality of life through 
ongoing management of the patient is necessary (26). According 
to prior studies, providing HOT as a means for management 
of COPD can prevent the loss of quality of life of the 
patients (27-29). Regarding any alternatives to prevent for 
progression of COPD patients were lacked, positive roles of 
usage HOT would be effective alternative in managing severe 
patients with other disease such as lung cancer, and etc. In 
addition, it is expected that usage of HOT would be positive 
effect to management for terminally-ill patients in other arena 
such as home hospice care.
The finding that COPD patients with grade 3 were much 
less likely than those with grade 1 and 2 to use HOT 
suggests that the payer should consider expanding insurance 
coverage for the service to those with grade 3. Given that 
using HOT helps slow down the progression of the disease, it 
would be beneficial for the patients who are less severe to 
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Table 1. Demographic Characteristics by Usage of Home Oxygen Therapy (frequency, %).
HOT
Use Non-use
Total Deterioration Maintenance or Mitigation P-value
Total Deterioration Maintenance or Mitigation P-value
N N % N % N N % N %
The grade of respiratory 
impairment
  Grade 1 1,418  370 26.1 1,048 73.9   0.5479 1,072  301 28.1  771 71.9 ＜0.0001
  Grade 2 1,516  393 25.9 1,123 74.1 1,928  579 30.0 1,349 70.0
  Grade 3 1,437  396 27.6 1,041 72.4 3,427 1,200 35.0 2,227 65.0
Sex
  Male 3,552  896 25.2 2,656 74.8 ＜0.0001 5,137 1,731 33.7 3,406 66.3 ＜0.0001
  Female  819  263 32.1  556 67.9 1,290  349 27.1  941 72.9
Age (years)
  ∼49 1,841  411 22.3 1,430 77.7 ＜0.0001 3,182  844 26.5 2,338 73.5 ＜0.0001
  50∼59 1,715  466 27.2 1,249 72.8 2,223  818 36.8 1,405 63.2
  60∼69  658  212 32.2  446 67.8  869  337 38.8  532 61.2
  70∼  157   70 44.6   87 55.4  153   81 52.9   72 47.1
Types of medical institution
  General hospital 3,638 1,024 28.1 2,614 71.9 ＜0.0001 4,453 1,674 37.6 2,779 62.4 ＜0.0001
  Hospital, Clinic  733  135 18.4  598 81.6 1,974  406 20.6 1,568 79.4
Length of stay
  Within 10 days 2,154  634 29.4 1,520 70.6 ＜0.0001 3,490 1,325 38.0 2,165 62.0 ＜0.0001
  10∼29 days 1,712  453 26.5 1,259 73.5 2,253  694 30.8 1,559 69.2
  More than 30 days  505   72 14.3  433 85.7  684   61  8.9  623 91.1
Experience of care in ICU
  Yes 94   42 44.7   52 55.3 ＜0.0001   82   41 50.0   41 50.0   0.0006
  No 4,277 1,117 26.1 3,160 73.9 6,345 2,039 32.1 4,306 67.9
Experience of ventilator care
  Yes  389   94 24.2  295 75.8   0.2711  167   57 34.1  110 65.9   0.6207
  No 3,982 1,065 26.7 2,917 73.3 6,260 2,023 32.3 4,237 67.7
Years
  2007  243  151 62.1   92 37.9 ＜0.0001  506  333 65.8  173 34.2 ＜0.0001
  2008  377  151 40.1  226 59.9  653  283 43.3  370 56.7
  2009  566  191 33.7  375 66.3  895  328 36.6  567 63.4
  2010  765  210 27.5  555 72.5 1,143  370 32.4  773 67.6
  2011 1,022  222 21.7  800 78.3 1,401  350 25.0 1,051 75.0
  2012 1,398  234 16.7 1,164 83.3 1,829  416 22.7 1,413 77.3
Total 4,371 1,159 26.5 3,212 73.5 6,427 2,080 32.4 4,347 67.6
HOT: Home Oxygen Therapy, ICU: Intensive Care Unit. *P-values are for results of χ2 tests for categorical variables.
start using the service earlier, once they also are entitled to be 
covered.
The finding that patients who were hospitalized in general 
hospitals were more likely to use HOT than those who were 
stayed in hospitals or clinics may indicate that the former 
were either more severe or better informed about the service. 
A recent report suggests that many respiratory patients are 
either unaware of the fact that HOT service is covered by the 
NHIS scheme or unsure about the effectiveness, efficacy, and 
safety of using the service (30).
However, this study has some limitations. First, it would 
have been ideal had we been able to used information 
including all respiratory diseases. But, the data used in this 
study included only COPD patients who have experienced 
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Table 2. Factors Associated with the Use of HOT.
Usage of HOT
OR 95% CI
The grade of respiratory impairment
  Grade 1 1.00 - -
  Grade 2 0.60* 0.54 0.67
  Grade 3 0.33* 0.30 0.37
Sex
  Male 1.00 - -
  Female 0.86* 0.77 0.95
Age (years)
  ∼49 1.00 - -
  50∼59 1.18* 1.08 1.30
  60∼69 1.15* 1.02 1.30
  70∼ 1.38* 1.07 1.77
Types of medical institution
  Hospital, Clinic 1.00 - -
  General hospital 2.13* 1.92 2.37
Length of stay
  Within 10 days 1.00 - -
  10∼29 days 1.15* 1.06 1.26
  More than 30 days 1.25* 1.09 1.45
Experience of care in ICU
  Yes 1.00 - -
  No 0.98 0.70 1.38
Experience of ventilator care
  Yes 1.00 - -
  No 0.37* 0.30 0.45
Years
  2007 1.00 - -
  2008 1.26* 1.02 1.55
  2009 1.38* 1.13 1.67
  2010 1.50* 1.24 1.81
  2011 1.65* 1.37 1.98
  2012 1.68* 1.40 2.01
HOT: Home Oxygen Therapy, ICU: Intensive Care Unit, OR: Odds Ratio, CI: Confidence Interval. *The results were statistically significant, †OR 
and 95% CI for results by multiple logistic regression analysis.
hospitalization corresponding to Grades 1, 2, and 3 of 
respiratory impairment. Therefore, we were not able to 
consider any respiratory disorders such as polycythemia, 
pulmonary hypertension, and neuropsychological symptoms 
related to COPD. The results of this study cannot be applied 
to both respiratory disorders and patients with COPD. 
Second, this study did not consider the aspects of cost when 
analyzing the effect of HOT. Given that cost is an important 
factor in treatment and management of disease, this will limit 
establishment of measures for COPD. Finally, there is also 
limitation in that only HOT, and no other treatment for 
COPD, was considered.
Despite these limitations, this study examined the effect of 
utilizing treatment after enforcement of insurance coverage of 
HOT in 2006. In particular, the strength of this study is that 
the effect of HOT was indirectly examined through change in 
the grade of impairment. The results of this study would be 
helpful in development of a policy for management of COPD. 
In addition, it must be able to provide support for treatment 
of physical, emotional symptoms of COPD patients through 
other studies.
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Table 3.  Factors Associated with Slow Down the Progression of COPD.
Total
OR 95% CI
HOT
  Non-use 1.00 - -
  Use 1.41* 1.23 1.61
The grade of respiratory impairment
  Level 1 1.00 - -
  Level 2 1.04 0.87 1.24
  Level 3 0.89 0.75 1.05
Sex
  Male 1.00 - -
  Female 0.94 0.80 1.10
Age (years)
  ~49 1.00 - -
  50~59 0.86* 0.75 0.98
  60~69 0.73* 0.61 0.88
  70~ 0.53* 0.38 0.74
Types of Medical institution
  Hospital, Clinic 1.00 - -
  General hospital 0.59* 0.51 0.68
Length of stay
  Within 10 days 1.00 - -
  10~29 days 1.23* 1.10 1.37
  More than 30 days 2.54* 2.00 3.22
Experience of care in ICU
  Yes 1.00 - -
  No 1.17 0.79 1.74
Experience of ventilator care
  Yes 1.00 - -
  No 0.98 0.76 1.26
Years
  2007 1.00 - -
  2008 3.36* 2.67 4.23
  2009 4.48* 3.58 5.61
  2010 6.79* 5.45 8.47
  2011 10.67* 8.57 13.28
  2012 16.51* 13.30 20.48
Chronic obstructive pulmonary disease, HOT: Home Oxygen Therapy, ICU: Intensive Care Unit, OR: Odds Ratio, CI: Confidence Interval. *The 
results were statistically significant, †OR and 95% CI for results by generalized linear mixed model.
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요      약
목적: 2006년부터 가정산소치료 서비스에 대해 보장
을 시작함에 따라, 기준에 부합하는 사람들은 가정산소
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서비스이용에 대해 20%의 본인부담만을 지출하게 되었
다. 이 같은 제도의 도입은 환자의 가정산소치료 서비
스에 대한 부담을 경감시키게 됨에 따라 주요 이용자인 
만성 폐쇄성 폐질환 환자들에게 긍정적인 효과를 미쳤
을 것으로 예상된다. 하지만, 제도 도입 후 가정산소치
료 서비스 제도의 효과에 대한 연구가 많지 않았고, 실
증적 근거자료 또한 부족한 실정이다. 따라서, 본 연구
는 제도 도입 후, 가정산소치료 서비스가 만성 폐쇄성 
폐질환 환자들의 상태에 긍정적 영향을 미쳤는지를 알
아보고자 한다.
방법: 만성폐쇄성 폐질환으로 2007년부터 2012년까지 
병원을 방문한 사람(N=10,798)의 청구데이터를 분석에 
이용하였으며, 가정산소치료 서비스 제도 적용의 기준
인 호흡기장애등급에 따라 분포의 차이를 설명하기 위
해 χ2 test을 하였다. 또한, 가정산소치료 서비스 이용
에 대한 요인을 알아보고자 Multiple Logistic Regression 
Analysis을 하였으며, 가정산소치료 서비스 이용이 호흡
기장애등급의 변화에 어떠한 영향을 주었는지 알아보
고자 Generalized Linear Mixed Model 분석을 하였다.
결과: 분석대상 중 호흡기장애등급 1등급에 속하는 
대상은 2,490명이었으며, 2/3등급에 속하는 대상은 8,308 
명이었다. 가정산소치료 서비스 이용에 대해서는 호흡
기 장애등급 3등급이 1 또는 2등급에 비해 적게 이용하
였다(OR: 0.33, 95% CI: 0.30∼0.37). 또한, 가정산소치료
를 이용함에 따라 환자의 상태의 변화에 대해 분석한 
결과, 가정산소치료 이용자는 미이용자에 비해 상태의 
완화 또는 유지에 대해 높은 값을 보였다(OR: 1.41, 95% 
CI: 1.23∼1.61).
결론: 가정산소치료 서비스 이용은 만성 폐쇄성 폐질
환 환자의 상태 악화방지에 대해서 긍정적인 영향을 준
다.
중심단어: 만성폐쇄성 폐질환, 산소흡입치료, 가정치료, 
호흡역학
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